Most neuromuscular disorders are rare (orphan) diseases, meaning that fewer than 1 in 2000 people are affected. They all cause a weakening of muscles, which could lead to tremendous disability. Because of this, international collaboration is extremely important to accelerate our knowledge and discovery of new medicines in the field of neuromuscular diseases.
ENMC reviews workshop applications bi-annually in March and September.
Next submission deadline: 1 September 2022
Guidelines how to provide care to neuromuscular patients who are affected by Covid-19:
Link to: WMS COVID-19 position and advice (updated 23-04-22)
Link to: WMS advice on vaccines and therapeutics (updated 23-04-2022)
Go to: translations
Go to: WMS site
This is ENMC at a glance:
https://www.enmc.org/wp-content/uploads/2019/02/Ferreiro.jpg
287
200
Alexandra Breukel
https://www.enmc.org/wp-content/uploads/2018/07/logo-224x300.png
Alexandra Breukel2019-01-21 15:26:352019-02-06 12:51:26New ENMC Research Director !
https://www.enmc.org/wp-content/uploads/2018/11/1.-Aanzicht-CY.jpg
840
1260
anymazed
https://www.enmc.org/wp-content/uploads/2018/07/logo-224x300.png
anymazed2018-07-23 17:16:392019-03-20 13:26:04Announcement: As of 2018, ENMC relocated its workshop venue“The mission of ENMC is to encourage and facilitate communication and collaboration in the field of neuromuscular research with the aim of improving diagnosis and prognosis, finding effective treatments and optimising standards of care to improve the quality of life of people affected by neuromuscular disorders.”
New updates World Muscle Society (WMS) guidelines on Covid-19 and vaccines16 May 2022 - 10:47
NEW: Themed workshop applications!7 June 2021 - 15:36
Updated application guidelines6 May 2021 - 14:23
ENMC travel preferences to contribute to reductions in CO2 emissions25 January 2021 - 12:40
Job vacancies at the ENMC!2 November 2020 - 17:00